Skip to content

Flexima™ Nasobiliary Catheter M00540120Recalls & reported problems

Boston Scientific Corporation · Nasobiliary Catheter · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 08714729337386), received between Dec 20, 2016 and Sep 5, 2025 — classified as 6 malfunctions.

The most frequently reported specific device problem is “Break” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 2 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break2
  • Device Contaminated During Manufacture or Shipping2
  • Detachment of Device or Device Component1
  • Material Separation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • No Consequences Or Impact To Patient3

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 5, 2025Break; Break

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA NASOBILIARY CATHETER WAS USED IN THE GALLBLADDER TO TREAT A COMMON BILE DUCT STONE DURING A PROCEDURE PERFORMED ON (B)(6), 2025. DURING THE PROCEDURE, THE DEVICE RUPTURED. ANOTHER OF THE SAME DEVICE WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT AND THE PATIENT CONDITION AFTER THE PROCEDURE WAS REPORTED TO BE STABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22982248 ↗
  • MalfunctionJul 28, 2025Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN FLEXIMA NASOBILIARY CATHTER WAS TO BE USED IN A PROCEDURE PERFORMED ON (B)(6) 2025. IT WAS REPORTED THAT THERE WERE FOREIGN OBJECTS NOTED INSIDE THE INNER BAG (THE PART WHERE THE PACKAGE INSERT IS INSERTED). THERE WAS NO PATIENT INVOLVEMENT. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE WAS USED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22639867 ↗
  • MalfunctionJul 28, 2025Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN FLEXIMA NASOBILIARY CATHTER WAS TO BE USED IN A PROCEDURE PERFORMED ON (B)(6) 2025. IT WAS REPORTED THAT THERE WERE FOREIGN OBJECTS NOTED INSIDE THE INNER BAG (THE PART WHERE THE PACKAGE INSERT IS INSERTED). THERE WAS NO PATIENT INVOLVEMENT. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE WAS USED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22639866 ↗
  • MalfunctionMar 20, 2017Detachment of Device or Device Component; Detachment of Device or Device Component

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA NASOBILIARY CATHETER WAS OPENED FOR USED IN THE BILE DUCT FOR AN ENDOSCOPIC NASOBILIARY DRAINAGE (ENBD) PROCEDURE. ACCORDING TO THE COMPLAINANT, DURING PREPARATION THE CONNECTING PART OF DARK BLUE AND PALE BLUE TUBE IN THE WORKING LENGTH GOT SEPARATED. THE PROCEDURE WAS COMPLETED WITH ANOTHER FLEXIMA NASOBILIARY CATHETER. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6419221 ↗
  • MalfunctionMar 9, 2017Material Separation; Material Separation

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA¿ NASOBILIARY CATHETER WAS USED IN THE COMMON BILE DUCT DURING AN ENDOSCOPIC NASOBILIARY DRAINAGE (ENBD) PLACEMENT PERFORMED ON (B)(6) 2017. ACCORDING TO THE COMPLAINANT, DURING PREPARATION, WHILE REMOVING THE WORKING LENGTH OF CATHETER FROM THE HOLDER, THE CATHETER GOT SEPARATED FROM THE JOINT OF THE RIGID PART. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6392973 ↗
  • MalfunctionDec 20, 2016Break; Break

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A NASOBILIARY CATHETER WAS OPENED FOR USE DURING A ENDOSCOPIC NASOBILIARY DRAINAGE (ENBD) PROCEDURE PERFORMED ON (B)(6) 2016. ACCORDING TO THE COMPLAINANT, DURING PREPARATION THE CATHETER GOT DETACHED WHEN REMOVED FROM THE POUCH. THE PROCEDURE WAS COMPLETED WITH ANOTHER NASOBILIARY CATHETER. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION REGARDING THE CIRCUMSTANCES SURROUNDING THIS EVENT HAVE BEEN UNSUCCESSFUL TO DATE. SHOULD ADDITIONAL RELEVANT DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6191294 ↗

Other CATHETER, BILIARY, DIAGNOSTIC devices

All CATHETER, BILIARY, DIAGNOSTIC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page